PARIS/NEW YORK, Dec 27 (Reuters) - France's Sanofi
has filed a lawsuit in the United States accusing Novo Nordisk
of falsely claiming that Sanofi insulin drugs would
no longer be available for many U.S. patients so it could
promote its competing drug.
Read more
No comments:
Post a Comment